{"entity":{"id":"nct07648030","kind":"trial","name":"A Study of Rusfertide in Japanese Adults With Polycythemia Vera","aka":[],"tldr":"A phase 2 trial of Rusfertide in myeloproliferative neoplasms, run by Takeda, now recruiting.","summary":"A Study of Rusfertide in Japanese Adults With Polycythemia Vera is a phase 2 interventional study registered as NCT07648030 by Takeda, with 9 participants planned, started 2026-07-14 and due to reach its primary completion in 2027-10-28. Interventions recorded: Rusfertide.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07648030","url":"https://clinicaltrials.gov/study/NCT07648030"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["myeloproliferative-neoplasms"],"sections":[],"technologies":["peptide-drug-conjugate"],"targets":[],"drugs":["rusfertide"],"companies":["takeda"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07648030","phase":"2","setting":"A Phase 2 Open-label Trial to Evaluate the Efficacy and Safety of Rusfertide in Japanese Patients With Polycythemia Vera","sponsor":"Takeda","started":"2026-07-14","startedType":"actual","enrolled":9,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07648030/","neighbours":{"cancer":[{"id":"myeloproliferative-neoplasms","kind":"cancer","name":"Myeloproliferative neoplasms (PV, ET, myelofibrosis)","route":"/cancers/myeloproliferative-neoplasms/"}],"technology":[{"id":"peptide-drug-conjugate","kind":"technology","name":"Peptide-drug & small-molecule-drug conjugates","route":"/technologies/peptide-drug-conjugate/"}],"drug":[{"id":"rusfertide","kind":"drug","name":"Rusfertide","route":"/drugs/rusfertide/"}],"company":[{"id":"takeda","kind":"company","name":"Takeda","route":"/companies/takeda/"}]}}